drugset / Trial / NCT01107938
Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to evaluate the efficacy and tolerability of ilaprazole relative to that of esomeprazole in healing erosive esophagitis and resolving accompanying symptoms of GERD.
Timeline
- Start
- 2010-05
- Primary completion
- 2010-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Esomeprazole | Small molecule | 40 mg | Oral |
| Subject | Ilaprazole | Small molecule | 10 mg | Oral |
| Subject | Ilaprazole | Small molecule | 15 mg | Oral |